We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02551432
Brief Title: Pembrolizumab and Paclitaxel in Refractory Small Cell Lung Cancer (MISP-MK3475)

First Submitted : July 7, 2015
First Submitted that Met QC Criteria : September 15, 2015
First Posted : September 16, 2015 (Estimate)

Results First Submitted : November 25, 2019
Results First Submitted that Met QC Criteria : February 7, 2020
Results First Posted : February 10, 2020

Last Update Submitted that Met QC Criteria : February 7, 2020
Last Update Posted : February 10, 2020